APA (7th ed.) Citation

N, S., M, C., V, R., Y, T., A, P., K, P., & S, H. (2025). Sphingosine-1-Phosphate (S1P) Receptor Modulators for the Treatment of Inflammatory Bowel Disease (IBD): Mechanisms, Clinical Evidence, and Practical Insights. Biomedicines, 13(11), . https://doi.org/10.3390/biomedicines13112655

Chicago Style (17th ed.) Citation

N, Shields, Colwill M, Raspa V, Twum-Danso Y, Poullis A, Patel K, and Honap S. "Sphingosine-1-Phosphate (S1P) Receptor Modulators for the Treatment of Inflammatory Bowel Disease (IBD): Mechanisms, Clinical Evidence, and Practical Insights." Biomedicines 13, no. 11 (2025). https://doi.org/10.3390/biomedicines13112655.

MLA (9th ed.) Citation

N, Shields, et al. "Sphingosine-1-Phosphate (S1P) Receptor Modulators for the Treatment of Inflammatory Bowel Disease (IBD): Mechanisms, Clinical Evidence, and Practical Insights." Biomedicines, vol. 13, no. 11, 2025, https://doi.org/10.3390/biomedicines13112655.